Related references
Note: Only part of the references are listed.Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells
Yu Zhang et al.
CANCER LETTERS (2009)
Mutations of ASXL1 gene in myeloproliferative neoplasms
N. Carbuccia et al.
LEUKEMIA (2009)
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2009)
Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays
Li Wang et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Sox7 is an independent checkpoint for β-catenin function in prostate and colon epithelial cells
Lizheng Guo et al.
MOLECULAR CANCER RESEARCH (2008)
CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells
Linhua Jin et al.
MOLECULAR CANCER THERAPEUTICS (2008)
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan et al.
NATURE (2008)
Variable breakpoints target PAX5 in patients with dicentric chromosomes: A model for the basis of unbalanced translocations in cancer
Qian An et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali et al.
BLOOD (2007)
Drp1 mediates caspase-independent type III cell death in normal and leukemic cells
Marlene Bras et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells
Naofumi Kagara et al.
CANCER SCIENCE (2007)
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
Timothy Hughes et al.
BLOOD (2006)
Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization
N Hosoya et al.
GENES CHROMOSOMES & CANCER (2006)
HTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia
LJ Campbell et al.
LEUKEMIA (2006)
Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family
CL Fisher et al.
GENE (2006)
Extended tracts of homozygosity in outbred human populations
J Gibson et al.
HUMAN MOLECULAR GENETICS (2006)
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias
J Fitzgibbon et al.
CANCER RESEARCH (2005)
Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22
NP Curtiss et al.
GENOMICS (2005)
P210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression
JF Geay et al.
CANCER RESEARCH (2005)
Innovation - Control of DNA replication and its potential clinical exploitation
MA Gonzalez et al.
NATURE REVIEWS CANCER (2005)
MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8
H Tagawa et al.
ONCOGENE (2004)
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over- representation
SM Gribble et al.
GENES CHROMOSOMES & CANCER (2003)
Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: Correlation with clinical parameters
S Papagerakis et al.
HUMAN PATHOLOGY (2003)
Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia
L Wang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Chronic myelogenous leukemia: mechanisms underlying disease progression
AS Shet et al.
LEUKEMIA (2002)
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia
B Johansson et al.
ACTA HAEMATOLOGICA (2002)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
